163 related articles for article (PubMed ID: 35699217)
1. Orbital Implants Receiving Food and Drug Administration Premarket Notification.
Corcoran Ruiz KM; Vaishnav YJ; Desautels J; Schaefer JL; Migliori ME; Yilmaz T
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):503-506. PubMed ID: 35699217
[TBL] [Abstract][Full Text] [Related]
2. Shoulder arthroplasty device clearance: an ancestral network analysis.
Zhu A; Ying X; Carey EG; Pean CA; Premkumar A; Fu MC; Taylor SA
J Shoulder Elbow Surg; 2023 Mar; 32(3):671-676. PubMed ID: 36279987
[TBL] [Abstract][Full Text] [Related]
3. The Complex Process of Using the Interconnected Knee Arthroplasty Device Clearance Pathway.
Zhu A; Ying X; Pean CA; Sheth NP; Cross MB; Gonzalez Della Valle A; Premkumar A
HSS J; 2022 Nov; 18(4):462-468. PubMed ID: 36258781
[No Abstract] [Full Text] [Related]
4. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
Samuel AM; Rathi VK; Grauer JN; Ross JS
Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
[TBL] [Abstract][Full Text] [Related]
5. The Interconnected Ancestral Network of Hip Arthroplasty Device Approval.
Premkumar A; Zhu A; Ying X; Pean CA; Sheth NP; Cross MB; Gonzalez Della Valle A
J Am Acad Orthop Surg; 2021 Dec; 29(24):e1362-e1369. PubMed ID: 34161960
[TBL] [Abstract][Full Text] [Related]
6. Mapping the genealogy of medical device predicates in the United States.
Pai DB
PLoS One; 2021; 16(10):e0258153. PubMed ID: 34618861
[TBL] [Abstract][Full Text] [Related]
7. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
Dubin JR; Simon SD; Norrell K; Perera J; Gowen J; Cil A
JAMA Netw Open; 2021 May; 4(5):e217274. PubMed ID: 33956132
[TBL] [Abstract][Full Text] [Related]
8. Analysis of FDA-Approved Orthopaedic Devices and Their Recalls.
Day CS; Park DJ; Rozenshteyn FS; Owusu-Sarpong N; Gonzalez A
J Bone Joint Surg Am; 2016 Mar; 98(6):517-24. PubMed ID: 26984921
[TBL] [Abstract][Full Text] [Related]
9. New orthopedic devices and the FDA.
Sheth U; Nguyen NA; Gaines S; Bhandari M; Mehlman CT; Klein G
J Long Term Eff Med Implants; 2009; 19(3):173-84. PubMed ID: 20939777
[TBL] [Abstract][Full Text] [Related]
10. Medical device recalls and the FDA approval process.
Zuckerman DM; Brown P; Nissen SE
Arch Intern Med; 2011 Jun; 171(11):1006-11. PubMed ID: 21321283
[TBL] [Abstract][Full Text] [Related]
11. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
[TBL] [Abstract][Full Text] [Related]
12. US Food and Drug Administration Clearance of Moderate-Risk Otolaryngologic Devices via the 510(k) Process, 1997-2016.
Rathi VK; Gadkaree SK; Ross JS; Kozin ED; Sethi RK; Naunheim MR; Puram SV; Gray ST
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):608-617. PubMed ID: 28786317
[TBL] [Abstract][Full Text] [Related]
13. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
Peters W; Pellerin C; Janney C
Biomed Instrum Technol; 2020 Nov; 54(6):418-426. PubMed ID: 33339030
[TBL] [Abstract][Full Text] [Related]
14. Recall Rates of Total Knee Arthroplasty Devices Are Dependent on the FDA Approval Process.
Pellerin C; Adamson M; Janney C
Cureus; 2020 Aug; 12(8):e9744. PubMed ID: 32944459
[TBL] [Abstract][Full Text] [Related]
15. Medical devices: US medical device regulation.
Jarow JP; Baxley JH
Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
[TBL] [Abstract][Full Text] [Related]
16. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
Tylenda CA; Weintraub M
Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
[TBL] [Abstract][Full Text] [Related]
17. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
19. Dermatologic Device Clearance Within the Food and Drug Administration's 510(k) Pathway.
Ezaldein HH; Hill ST; Merati M; Suggs A; Reichert B; Scott JF
Lasers Surg Med; 2020 Nov; 52(9):837-841. PubMed ID: 32221981
[TBL] [Abstract][Full Text] [Related]
20. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
Everhart AO; Sen S; Stern AD; Zhu Y; Karaca-Mandic P
JAMA; 2023 Jan; 329(2):144-156. PubMed ID: 36625811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]